What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
SAPRA
1 other identifier
observational
118
1 country
1
Brief Summary
Anaphylaxis is an allergic reaction potentially fatal. The treatment is based on injection of epinephrin as soon as possible. Guidelines by the World Allergic Organisation highlight the importance of medical follow-up. This follow-up consists of an allergy consultation, the prescription and demonstration of epinephrin auto-injector and the implementation of specific measures in schools. There is no study about the recurrence of anaphylactic reaction outside the hospital. The purpose of this study is to evaluate the allergy follow-up of children after anaphylactic reaction. The secondary objective is to evaluate the use of medical advice in case of recurrence of anaphylactic reaction. Investigators will use a phone call questionnaire for parents of children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in the Paediatric Emergency Department in Femme-Mère-Enfant Hospital in Lyon in France. 179 children could be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2019
CompletedFirst Posted
Study publicly available on registry
May 8, 2019
CompletedStudy Start
First participant enrolled
May 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2019
CompletedOctober 9, 2019
October 1, 2019
3 months
May 7, 2019
October 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Allergy follow-up
Allergy follow-up evaluation with : * the frequency of consultations with an allergist * the information of the general practitioner or pediatrician * the prescription of epinephrin auto-injector * the frequency of renewal of epinephrin auto-injector * the specialty of doctor who prescribed the renewal * the implementation of specific measures in schools * the frequency of renewal of specific measures in schools * the number of recurrence of anaphylactic reaction * the use of medical advice in case of recurrence of anaphylactic reaction
About 15 minutes
Study Arms (1)
Children with anaphylactic reaction
Children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France.
Interventions
Questionnaire for parents of subject about : * the frequency of consultations with an allergist * the information of the general practitioner or pediatrician * the prescription of epinephrin auto-injector * the frequency of renewal of epinephrin auto-injector * the specialty of doctor who prescribed the renewal * the implementation of specific measures in schools * the frequency of renewal of specific measures in schools * the number of recurrence of anaphylactic reaction * the use of medical advice in case of recurrence of anaphylactic reaction
Eligibility Criteria
Children from 0 to 18 year old who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France.
You may qualify if:
- Age from 0 to 17
- Anaphylactic reaction meeting the criteria of Sampson et al. treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France
- Anaphylactic reaction treated between the 1st July 2014 and the 31st June 2016
You may not qualify if:
- \- No agreement from patient or parents to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Paediatric Emergency Department in Femme-Mère-Enfant Hospital
Bron, 69677, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2019
First Posted
May 8, 2019
Study Start
May 21, 2019
Primary Completion
August 20, 2019
Study Completion
August 20, 2019
Last Updated
October 9, 2019
Record last verified: 2019-10